Acutus Medical, Inc. (AFIB) Misses Q2 EPS by 13c

Acutus Medical, Inc. (NASDAQ: AFIB) reported Q2 EPS of ($0.93), $0.13 worse than the analyst estimate of ($0.80). Revenue for the quarter came in at $4.1 million versus the consensus estimate of $3.84 million.

For earnings history and earnings-related data on Acutus Medical, Inc. (AFIB) click here.

You May Also Be Interested In

• Synopsys upgraded at Piper Sandler on Intel foundry momentum, Apple opportunity
• Primoris cuts 2026 outlook on renewables cost overruns, COO exits
• Piper Sandler on Fervo Energy (FRVO): 'Capital Access Supports Potential Upside'